Related references
Note: Only part of the references are listed.Troponin T levels in patients with acute heart failure: clinical and prognostic significance of their detection and release during hospitalisation
Marco Metra et al.
CLINICAL RESEARCH IN CARDIOLOGY (2012)
Rationale and design of ARTS: a randomized, double-blind study of BAY 94-8862 in patients with chronic heart failure and mild or moderate chronic kidney disease
Bertram Pitt et al.
EUROPEAN JOURNAL OF HEART FAILURE (2012)
A comprehensive, longitudinal description of the in-hospital and post-discharge clinical, laboratory, and neurohormonal course of patients with heart failure who die or are re-hospitalized within 90 days: analysis from the EVEREST trial
Mihai Gheorghiade et al.
HEART FAILURE REVIEWS (2012)
Prognostic Importance of Early Worsening Renal Function After Initiation of Angiotensin-Converting Enzyme Inhibitor Therapy in Patients With Cardiac Dysfunction
Jeffrey M. Testani et al.
CIRCULATION-HEART FAILURE (2011)
Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms.
Faiez Zannad et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Troponin Elevation in Heart Failure Prevalence, Mechanisms, and Clinical Implications
Robb D. Kociol et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
Heart Disease and Stroke Statistics-2009 Update A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee
Donald Lloyd-Jones et al.
CIRCULATION (2009)
Timing of eplerenone initiation and outcomes in patients with heart failure after acute myocardial infarction complicated by left ventricular systolic dysfunction: insights from the EPHESUS trial
Chris Adamopoulos et al.
EUROPEAN JOURNAL OF HEART FAILURE (2009)
Continental Differences in Clinical Characteristics, Management, and Outcomes in Patients Hospitalized With Worsening Heart Failure Results From the EVEREST (Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan) Program
John E. A. Blair et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Effect of post-myocardial infarction exercise training on the renin-angiotensin-aldosterone system and cardiac function
Wenhan Wan et al.
AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2007)
Complementary and incremental mortality risk prediction by cortisol and aldosterone in chronic heart failure
Guelmisal Gueder et al.
CIRCULATION (2007)
Effects of oral tolvaptan in patients hospitalized for worsening heart failure - The EVEREST outcome trial
Marvin A. Konstam et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Association between performance measures and clinical outcomes for patients hospitalized with heart failure
Gregg C. Fonarow et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
The incidence and implications of aldosterone breakthrough
Andrew S. Bomback et al.
NATURE CLINICAL PRACTICE NEPHROLOGY (2007)
High plasma aldosterone levels on admission are associated with death in patients presenting with acute ST-elevation myocardial infarction
Farzin Beygui et al.
CIRCULATION (2006)
Reassessing treatment of acute heart failure syndromes: the ADHERE Registry
M Gheorghiade et al.
EUROPEAN HEART JOURNAL SUPPLEMENTS (2005)
The comparative prognostic value of plasma neurohormones at baseline in patients with heart failure enrolled in Val-HeFT
R Latini et al.
EUROPEAN HEART JOURNAL (2004)
Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction
B Pitt et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Diuretic therapy and resistance in congestive heart failure
DH Ellison
CARDIOLOGY (2001)
Share Paper
